Cargando…
Assessing Psychiatric Comorbidity and Pharmacologic Treatment Patterns Among Patients With Neurofibromatosis Type 1
Background and objective Neurofibromatosis 1 (NF1) is a genetic disorder that is accompanied by psychiatric comorbidities such as depression, anxiety, and attention-deficit hyperactivity disorder (ADHD) in more than half of the patients. However, there are limited data describing optimal treatment s...
Autores principales: | Houpt, Alexander C, Schwartz, Shaina E, Coover, Robert A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735883/ https://www.ncbi.nlm.nih.gov/pubmed/35004058 http://dx.doi.org/10.7759/cureus.20244 |
Ejemplares similares
-
Temporal Lobe Epilepsy and Psychiatric Comorbidity
por: Vinti, Valerio, et al.
Publicado: (2021) -
A Review of Psychiatric Comorbidity in Myasthenia Gravis
por: Law, Christina, et al.
Publicado: (2020) -
Polysomnographic study in pediatric neurofibromatosis type 1
por: Carotenuto, Marco, et al.
Publicado: (2023) -
Massive Hemorrhage Following Acupuncture Treatment in a Neurofibromatosis Type 1 Patient
por: Wei, Wei, et al.
Publicado: (2023) -
Comorbidities and Antithrombotic Treatment Pattern in Patients With Atrial Fibrillation
por: Bang, Oh Young, et al.
Publicado: (2022)